N 6 ‐Methyladenosine (m 6 A) in Liver Disease: Pathogenic Mechanisms and Therapeutic Potential
Authors:
Open Access
- 17 March 2026
- journal article
- review article
- Published by Wiley in iNew Medicine
- Vol. 2 (2) , e70036
Abstract
Accumulating evidence highlights the critical role of epigenetic modifications, particularly N 6 ‐methyladenosine (m 6 A), in liver disease. As the most abundant RNA modification in eukaryotic cells, m 6 A is dynamically regulated by multicomponent m 6 A methyltransferases (e.g., METTL3 and METTL14), demethylases (FTO and ALKBH5), and m 6 A‐binding proteins (YTHDF1/2/3, YTHDC1/2, and IGF2BP1/2/3). Recent studies have revealed the pivotal involvement of m 6 A and its regulators in a wide range of physiological and pathological processes in liver disease, including metabolic dysfunction‐associated steatotic liver disease (MASLD), liver fibrosis, hepatocellular carcinoma (HCC), as well as liver injury and regeneration. In this review, we summarize recent advances in understanding the emerging roles of m 6 A modifications in liver disease and discuss their potential as therapeutic targets, offering new perspectives for treating liver disease.Keywords
Funding Information
- National Key Research and Development Program of China (2023YFA1800804)
This publication has 108 references indexed in Scilit:
- PXR Activation Relieves Deoxynivalenol‐Induced Liver Oxidative Stress Via Malat1 LncRNA m6A DemethylationAdvanced Science, 2024
- Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapyMedcomm, 2024
- YTHDF2 Is a Therapeutic Target for HCC by Suppressing Immune Evasion and Angiogenesis Through ETV5/PD‐L1/VEGFA AxisAdvanced Science, 2024
- Insufficient Radiofrequency Ablation Promotes Hepatocellular Carcinoma Metastasis Through N6‐Methyladenosine mRNA Methylation‐Dependent MechanismHepatology, 2021
- Emerging roles of SIRT6 in human diseases and its modulatorsMedicinal Research Reviews, 2020
- HBV‐Induced Increased N6 Methyladenosine Modification of PTEN RNA Affects Innate Immunity and Contributes to HCCHepatology, 2020
- N6‐Methyladenosine Reader Protein YT521‐B Homology Domain‐Containing 2 Suppresses Liver Steatosis by Regulation of mRNA Stability of Lipogenic GenesHepatology, 2020
- RNA N6‐methyladenosine methyltransferase‐like 3 promotes liver cancer progression through YTHDF2‐dependent posttranscriptional silencing of SOCS2Hepatology, 2017
- METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulating N 6‐methyladenosine‐dependent primary MicroRNA processingHepatology, 2016
- Rubicon inhibits autophagy and accelerates hepatocyte apoptosis and lipid accumulation in nonalcoholic fatty liver disease in miceHepatology, 2016